The forecast for anti-infective medicine sales in the UK suggests a steady increase from 2024 to 2028, with sales expected to rise from $3.94 billion to $4.18 billion over this period. The year-on-year growth rate remains constant at approximately 1.5%. In 2023, the value stood at $3.88 billion, indicating a consistent upward trend. The compound annual growth rate (CAGR) over the five-year forecast period (2024-2028) is anticipated to be around 1.5%, suggesting stable growth in the anti-infective medicines sector.

Future trends to watch for include:

Potential impact of new regulations or policies on drug pricing.
Advancements in medical technology and drug development.
Changes in healthcare funding and prioritization within the NHS.
Emergence of antibiotic resistance influencing demand and innovation in the sector.